Table 4. Candidate lncRNAs and clinicopathological factors for predicting liver metastases in patients with stage I/II CRC.
| Factors | Subset | Univariate | Multivariate | ||
|---|---|---|---|---|---|
| P value | Relative risk | 95% CI | P value | ||
| Age (year) | ≤ 50 / > 50 | 0.0399 | 0.3 | 0.10 - 0.86 | 0.0257 |
| Gender | Male / Female | 0.3334 | - | - | - |
| Organ | Colon / Rectum / C&R | 0.1455 | - | - | - |
| Deptha | T1 / T2 / T3 / T4 | 0.0137 | 2.2 | 1.16 - 4.29 | 0.0173 |
| LVI | Positive / Negative | 0.6198 | - | - | - |
| Histologic grade | I / II / III | 0.0317 | 2.6 | 0.95 - 7.24 | 0.0644 |
| GAS5 | High / Low | 0.0206 | 3.3 | 0.77 - 14.55 | 0.1105 |
| H19 | High / Low | 0.2474 | - | - | - |
| MEG3 | High / Low | 0.2024 | - | - | - |
| Yiya | High / Low | 0.0005 | 10.7 | 3.40 - 33.52 | 0.0001 |
According to Tumor-Node-Metastasis (TNM) Classification of Colorectal Carcinoma
High, high expression level ≥ mean 2ΔCq
Low, low expression level < mean 2ΔCq
CRC, colorectal cancer
C, colon; R, rectum; LVI, lymphatic vessel invasion; CI, confidence interval